This compound is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a BOC-protected amine and a trifluoromethyl group, makes it valuable for developing compounds with enhanced biological activity and metabolic stability. It is particularly useful in the preparation of piperidine-based drugs, which are common in treatments for neurological disorders, pain management, and cardiovascular diseases. Additionally, the trifluoromethyl group can improve the lipophilicity and bioavailability of the final drug molecules, making it a crucial building block in medicinal chemistry.